| Authors: |
Chang L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Jung NY; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Atari A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Rodriguez DJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kesar D; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Song TY; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Rees MG; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ronan M; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Li R; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ruiz P; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Chaturantabut S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Biopharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand., Ito T; Broad Institute of MIT and Harvard, Cambridge, MA, USA., van Tienen LM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Tseng YY; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Roth JA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sellers WR; Broad Institute of MIT and Harvard, Cambridge, MA, USA. wsellers@broadinstitute.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. wsellers@broadinstitute.org.; Harvard Medical School, Boston, MA, USA. wsellers@broadinstitute.org. |
